The investigator and sponsor are responsible for determining whether a trial is an
applicable clinical trial and to include the required statement in the informed consent
document, as appropriate, for approval by the IRB. If an error is made, the IRB should
be notified as soon as possible and a revised consent form that includes the required
statement should be provided to the IRB for review and approval.